{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:42:16Z","timestamp":1777005736185,"version":"3.51.4"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["81760572"],"award-info":[{"award-number":["81760572"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["81972986, 81703176"],"award-info":[{"award-number":["81972986, 81703176"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04793-0","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:29:08Z","timestamp":1773757748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DNA hypermethylation of choline kinases drives blockage of choline-phosphatidylcholine biosynthesis: lipidomic biomarkers and epigenetic insights of hepatic steatosis induced by arsenic"],"prefix":"10.1186","volume":"24","author":[{"given":"Qiwen","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingyi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingcheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hualin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaofeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"7","key":"4793_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022;22(7):429\u201343.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"4793_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"4793_CR3","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386.","journal-title":"Hepatology"},{"issue":"l","key":"4793_CR4","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(l):S32-50.","journal-title":"Clin Mol Hepatol"},{"key":"4793_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2021.106555","volume":"154","author":"S Zheng","year":"2021","unstructured":"Zheng S, Yang Y, Wen C, Liu W, Cao L, Feng X, et al. Effects of environmental contaminants in water resources on nonalcoholic fatty liver disease. Environ Int. 2021;154:106555.","journal-title":"Environ Int"},{"key":"4793_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1133194","volume":"11","author":"Z Xie","year":"2023","unstructured":"Xie Z, Aimuzi R, Si M, Qu Y, Jiang Y. Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003-2018. Front Public Health. 2023;11:1133194.","journal-title":"Front Public Health"},{"key":"4793_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2022.112697","volume":"208","author":"SF Farzan","year":"2022","unstructured":"Farzan SF, Eunus HM, Haque SE, Sarwar G, Hasan AR, Wu F, et al. Arsenic exposure from drinking water and endothelial dysfunction in Bangladeshi adolescents. Environ Res. 2022;208:112697.","journal-title":"Environ Res"},{"issue":"36","key":"4793_CR8","doi-asserted-by":"publisher","first-page":"50094","DOI":"10.1007\/s11356-021-14230-9","volume":"28","author":"RB Jain","year":"2021","unstructured":"Jain RB. Contribution of diet and other factors for urinary concentrations of total arsenic and arsenic species: data for US children, adolescents, and adults. Environ Sci Pollut Res Int. 2021;28(36):50094\u2013116.","journal-title":"Environ Sci Pollut Res Int"},{"issue":"6493","key":"4793_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1126\/science.aba1510","volume":"368","author":"J Podgorski","year":"2020","unstructured":"Podgorski J, Berg M. Global threat of arsenic in groundwater. Science. 2020;368(6493):845\u201350.","journal-title":"Science"},{"key":"4793_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2024.108819","volume":"190","author":"Q Liu","year":"2024","unstructured":"Liu Q, Li P, Ma J, Zhang J, Li W, Liu Y, et al. Arsenic exposure at environmentally relevant levels induced metabolic toxicity in development mice: mechanistic insights from integrated transcriptome and metabolome. Environ Int. 2024;190:108819.","journal-title":"Environ Int"},{"key":"4793_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2023.133329","volume":"465","author":"T Zhao","year":"2024","unstructured":"Zhao T, Sun D, Long K, Xiong W, Man J, Zhang Q, et al. N(6)-methyladenosine promotes aberrant redox homeostasis required for arsenic carcinogenesis by controlling the adaptation of key antioxidant enzymes. J Hazard Mater. 2024;465:133329.","journal-title":"J Hazard Mater"},{"key":"4793_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijheh.2024.114342","volume":"257","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li W, Zhang J, Yan Y, Zhou Q, Liu Q, et al. Associations of arsenic exposure and arsenic metabolism with the risk of non-alcoholic fatty liver disease. Int J Hyg Environ Health. 2024;257:114342.","journal-title":"Int J Hyg Environ Health"},{"issue":"1","key":"4793_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-017-0350-1","volume":"17","author":"JK Frediani","year":"2018","unstructured":"Frediani JK, Naioti EA, Vos MB, Figueroa J, Marsit CJ, Welsh JA. Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race\/ethnicity, NHANES 2005-2014. Environ Health. 2018;17(1):6.","journal-title":"Environ Health"},{"key":"4793_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.164746","volume":"892","author":"H Li","year":"2023","unstructured":"Li H, Wu L, Ye F, Wang D, Wang L, Li W, et al. As3MT via consuming SAM is involved in arsenic-induced nonalcoholic fatty liver disease by blocking m(6)A-mediated miR-142-5p maturation. Sci Total Environ. 2023;892:164746.","journal-title":"Sci Total Environ"},{"issue":"1","key":"4793_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3350\/cmh.2022.0237","volume":"29","author":"KC Lee","year":"2023","unstructured":"Lee KC, Wu PS, Lin HC. Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis. Clin Mol Hepatol. 2023;29(1):77\u201398.","journal-title":"Clin Mol Hepatol"},{"issue":"24","key":"4793_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415489","volume":"23","author":"X Guo","year":"2022","unstructured":"Guo X, Yin X, Liu Z, Wang J. Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. Int J Mol Sci. 2022;23(24):15489.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4793_CR17","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1080\/15548627.2021.1961072","volume":"18","author":"K Liu","year":"2022","unstructured":"Liu K, Qiu D, Liang X, Huang Y, Wang Y, Jia X, et al. Lipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy. Autophagy. 2022;18(4):860\u201376.","journal-title":"Autophagy"},{"issue":"1","key":"4793_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","volume":"15","author":"Y Geng","year":"2021","unstructured":"Geng Y, Faber KN, de Meijer VE, Blokzijl H, Moshage H. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Hepatol Int. 2021;15(1):21\u201335.","journal-title":"Hepatol Int"},{"issue":"18","key":"4793_CR19","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","volume":"81","author":"H Yoon","year":"2021","unstructured":"Yoon H, Shaw JL, Haigis MC, Greka A. Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity. Mol Cell. 2021;81(18):3708\u201330.","journal-title":"Mol Cell"},{"key":"4793_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101238","volume":"50","author":"J Heeren","year":"2021","unstructured":"Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab. 2021;50:101238.","journal-title":"Mol Metab"},{"key":"4793_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.semcdb.2020.04.011","volume":"108","author":"F Seebacher","year":"2020","unstructured":"Seebacher F, Zeigerer A, Kory N, Krahmer N. Hepatic lipid droplet homeostasis and fatty liver disease. Semin Cell Dev Biol. 2020;108:72\u201381.","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"4793_CR22","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1152\/physrev.00002.2020","volume":"101","author":"DJ Hoffman","year":"2021","unstructured":"Hoffman DJ, Powell TL, Barrett ES, Hardy DB. Developmental origins of metabolic diseases. Physiol Rev. 2021;101(3):739\u201395.","journal-title":"Physiol Rev"},{"issue":"1","key":"4793_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55\u201371.","journal-title":"Nat Rev Microbiol"},{"key":"4793_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.semcancer.2020.12.022","volume":"83","author":"L Guo","year":"2022","unstructured":"Guo L, Lee YT, Zhou Y, Huang Y. Targeting epigenetic regulatory machinery to overcome cancer therapy resistance. Semin Cancer Biol. 2022;83:487\u2013502.","journal-title":"Semin Cancer Biol"},{"key":"4793_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-biochem-080120-021109","volume":"90","author":"JD Bagert","year":"2021","unstructured":"Bagert JD, Muir TW. Molecular epigenetics: chemical biology tools come of age. Annu Rev Biochem. 2021;90:287\u2013320.","journal-title":"Annu Rev Biochem"},{"issue":"5","key":"4793_CR26","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ccell.2020.08.008","volume":"38","author":"RE Phillips","year":"2020","unstructured":"Phillips RE, Soshnev AA, Allis CD. Epigenomic reprogramming as a driver of malignant glioma. Cancer Cell. 2020;38(5):647\u201360.","journal-title":"Cancer Cell"},{"issue":"1","key":"4793_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00936-z","volume":"12","author":"HS Lee","year":"2020","unstructured":"Lee HS, Park T. The influences of DNA methylation and epigenetic clocks, on metabolic disease, in middle-aged Koreans. Clin Epigenetics. 2020;12(1):148.","journal-title":"Clin Epigenetics"},{"issue":"6","key":"4793_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","volume":"15","author":"M Kato","year":"2019","unstructured":"Kato M, Natarajan R. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat Rev Nephrol. 2019;15(6):327\u201345.","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"4793_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11119","volume":"8","author":"M Vachher","year":"2022","unstructured":"Vachher M, Bansal S, Kumar B, Yadav S, Burman A. Deciphering the role of aberrant DNA methylation in NAFLD and NASH. Heliyon. 2022;8(10):e11119.","journal-title":"Heliyon"},{"issue":"36","key":"4793_CR30","doi-asserted-by":"publisher","first-page":"50489","DOI":"10.1007\/s11356-021-14273-y","volume":"28","author":"M Yao","year":"2021","unstructured":"Yao M, Zeng Q, Luo P, Sun B, Liang B, Wei S, et al. Assessing the risk of coal-burning arsenic-induced liver damage: a population-based study on hair arsenic and cumulative arsenic. Environ Sci Pollut Res Int. 2021;28(36):50489\u201399.","journal-title":"Environ Sci Pollut Res Int"},{"key":"4793_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.envint.2019.05.005","volume":"129","author":"D Wang","year":"2019","unstructured":"Wang D, Luo P, Zou Z, Wang Q, Yao M, Yu C, et al. Alterations of arsenic levels in arsenicosis residents and awareness of its risk factors: a population-based 20-year follow-up study in a unique coal-borne arsenicosis county in Guizhou. China Environ Int. 2019;129:18\u201327.","journal-title":"China Environ Int"},{"key":"4793_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2023.122228","volume":"334","author":"L Ma","year":"2023","unstructured":"Ma L, Lv J, Zhang A. Depletion of S-adenosylmethionine induced by arsenic exposure is involved in liver injury of rat through perturbing histone H3K36 trimethylation dependent bile acid metabolism. Environ Pollut. 2023;334:122228.","journal-title":"Environ Pollut"},{"issue":"6","key":"4793_CR33","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.cmet.2023.02.014","volume":"35","author":"M Tsuchiya","year":"2023","unstructured":"Tsuchiya M, Tachibana N, Nagao K, Tamura T, Hamachi I. Organelle-selective click labeling coupled with flow cytometry allows pooled CRISPR screening of genes involved in phosphatidylcholine metabolism. Cell Metab. 2023;35(6):1072\u201383.","journal-title":"Cell Metab"},{"issue":"7","key":"4793_CR34","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","volume":"6","author":"G Targher","year":"2021","unstructured":"Targher G, Tilg H, Byrne CD. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol Hepatol. 2021;6(7):578\u201388.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"4793_CR35","doi-asserted-by":"publisher","first-page":"320","DOI":"10.23736\/S0031-0808.17.03359-6","volume":"59","author":"GP Caviglia","year":"2017","unstructured":"Caviglia GP, Rosso C, Fagoonee S, Saracco GM, Pellicano R. Liver fibrosis: the 2017 state of art. Panminerva Med. 2017;59(4):320\u201331.","journal-title":"Panminerva Med"},{"key":"4793_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2022.119915","volume":"311","author":"W Li","year":"2022","unstructured":"Li W, Xiao H, Wu H, Pan C, Deng K, Xu X, et al. Analysis of environmental chemical mixtures and nonalcoholic fatty liver disease: NHANES 1999-2014. Environ Pollut. 2022;311:119915.","journal-title":"Environ Pollut"},{"issue":"3","key":"4793_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","volume":"18","author":"J Maurice","year":"2018","unstructured":"Maurice J, Manousou P. Non-alcoholic fatty liver disease. Clin Med (Lond). 2018;18(3):245\u201350.","journal-title":"Clin Med (Lond)"},{"key":"4793_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2023.108381","volume":"183","author":"B Fan","year":"2024","unstructured":"Fan B, Cheng C, Yang Y, Wang P, Xia H, Wu M, et al. Construction of an adverse outcome pathway framework based on integrated data to evaluate arsenic-induced non-alcoholic fatty liver disease. Environ Int. 2024;183:108381.","journal-title":"Environ Int"},{"key":"4793_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.116310","volume":"276","author":"B Park","year":"2024","unstructured":"Park B, Kim B, Kim CH, Oh HJ, Park B. Association between endocrine-disrupting chemical mixtures and non-alcoholic fatty liver disease with metabolic syndrome as a mediator among adults: a population-based study in Korea. Ecotoxicol Environ Saf. 2024;276:116310.","journal-title":"Ecotoxicol Environ Saf"},{"key":"4793_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.toxlet.2019.10.010","volume":"319","author":"XY Zhu","year":"2020","unstructured":"Zhu XY, Xia HG, Wang ZH, Li B, Jiang HY, Li DL, et al. In vitro and in vivo approaches for identifying the role of aryl hydrocarbon receptor in the development of nonalcoholic fatty liver disease. Toxicol Lett. 2020;319:85\u201394.","journal-title":"Toxicol Lett"},{"issue":"1","key":"4793_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/toxsci\/kfm013","volume":"98","author":"JC Davey","year":"2007","unstructured":"Davey JC, Bodwell JE, Gosse JA, Hamilton JW. Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. Toxicol Sci. 2007;98(1):75\u201386.","journal-title":"Toxicol Sci"},{"issue":"5","key":"4793_CR42","doi-asserted-by":"publisher","first-page":"H1053","DOI":"10.1152\/ajpheart.00364.2018","volume":"316","author":"R Veenema","year":"2019","unstructured":"Veenema R, Casin KM, Sinha P, Kabir R, Mackowski N, Taube N, et al. Inorganic arsenic exposure induces sex-disparate effects and exacerbates ischemia-reperfusion injury in the female heart. Am J Physiol Heart Circ Physiol. 2019;316(5):H1053\u201364.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"4793_CR43","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1289\/ehp.1408663","volume":"123","author":"CF Huang","year":"2015","unstructured":"Huang CF, Yang CY, Chan DC, Wang CC, Huang KH, Wu CC, et al. Arsenic exposure and glucose intolerance\/insulin resistance in estrogen-deficient female mice. Environ Health Perspect. 2015;123(11):1138\u201344.","journal-title":"Environ Health Perspect"},{"issue":"4","key":"4793_CR44","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1542\/peds.2006-1212","volume":"118","author":"JB Schwimmer","year":"2006","unstructured":"Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118(4):1388\u201393.","journal-title":"Pediatrics"},{"issue":"1","key":"4793_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s12072-016-9772-z","volume":"11","author":"C Stern","year":"2017","unstructured":"Stern C, Castera L. Non-invasive diagnosis of hepatic steatosis. Hepatol Int. 2017;11(1):70\u20138.","journal-title":"Hepatol Int"},{"issue":"2","key":"4793_CR46","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1148\/radiol.2021204288","volume":"301","author":"J Starekova","year":"2021","unstructured":"Starekova J, Hernando D, Pickhardt PJ, Reeder SB. Quantification of liver fat content with CT and MRI: state of the art. Radiology. 2021;301(2):250\u201362.","journal-title":"Radiology"},{"key":"4793_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2022.120783","volume":"317","author":"R Xie","year":"2023","unstructured":"Xie R, Zhang Y. Is assessing the degree of hepatic steatosis and fibrosis based on index calculations the best choice for epidemiological studies? Environ Pollut. 2023;317:120783.","journal-title":"Environ Pollut"},{"issue":"4","key":"4793_CR48","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1053\/j.gastro.2023.05.053","volume":"165","author":"S Man","year":"2023","unstructured":"Man S, Deng Y, Ma Y, Fu J, Bao H, Yu C, et al. Prevalence of liver steatosis and fibrosis in the general population and various high-risk populations: a nationwide study with 5.7 million adults in China. Gastroenterology. 2023;165(4):1025\u201340.","journal-title":"Gastroenterology"},{"issue":"1","key":"4793_CR49","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12940-022-00945-w","volume":"21","author":"J Peng","year":"2023","unstructured":"Peng J, Du LL, Ma QL. Serum glycolipids mediate the relationship of urinary bisphenols with NAFLD: analysis of a population-based, cross-sectional study. Environ Health. 2023;21(1):124.","journal-title":"Environ Health"},{"key":"4793_CR50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI151895","author":"S Kawamura","year":"2022","unstructured":"Kawamura S, Matsushita Y, Kurosaki S, Tange M, Fujiwara N, Hayata Y, et al. Inhibiting SCAP\/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI151895.","journal-title":"J Clin Invest"},{"issue":"10","key":"4793_CR51","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1111\/liv.14174","volume":"39","author":"V Mannisto","year":"2019","unstructured":"Mannisto V, Kaminska D, Karja V, Tiainen M, de Mello VD, Hanhineva K, et al. Total liver phosphatidylcholine content associates with non-alcoholic steatohepatitis and glycine N-methyltransferase expression. Liver Int. 2019;39(10):1895\u2013905.","journal-title":"Liver Int"},{"issue":"10","key":"4793_CR52","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1007\/s00125-013-2981-2","volume":"56","author":"M Oresic","year":"2013","unstructured":"Oresic M, Hyotylainen T, Kotronen A, Gopalacharyulu P, Nygren H, Arola J, et al. Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids. Diabetologia. 2013;56(10):2266\u201374.","journal-title":"Diabetologia"},{"issue":"1","key":"4793_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29006-z","volume":"13","author":"O Alka","year":"2022","unstructured":"Alka O, Shanthamoorthy P, Witting M, Kleigrewe K, Kohlbacher O, Rost HL. DIAMetAlyzer allows automated false-discovery rate-controlled analysis for data-independent acquisition in metabolomics. Nat Commun. 2022;13(1):1347.","journal-title":"Nat Commun"},{"issue":"1","key":"4793_CR54","doi-asserted-by":"publisher","DOI":"10.5702\/massspectrometry.A0155","volume":"13","author":"F Matsuda","year":"2024","unstructured":"Matsuda F. Data processing of product ion spectra: methods to control false discovery rate in compound search results for untargeted metabolomics. Mass Spectrom (Tokyo). 2024;13(1):A0155.","journal-title":"Mass Spectrom (Tokyo)"},{"key":"4793_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep17221","volume":"5","author":"EY Chong","year":"2015","unstructured":"Chong EY, Huang Y, Wu H, Ghasemzadeh N, Uppal K, Quyyumi AA, et al. Local false discovery rate estimation using feature reliability in LC\/MS metabolomics data. Sci Rep. 2015;5:17221.","journal-title":"Sci Rep"},{"issue":"13","key":"4793_CR56","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.scib.2025.02.022","volume":"70","author":"J Zhang","year":"2025","unstructured":"Zhang J, Fu J, Duan C, Chen M, Wu W, Chen XM, et al. Identifying reproducible biomarkers for microbiome association studies requires thousands of sample sizes. Sci Bull. 2025;70(13):2056\u201360.","journal-title":"Sci Bull"},{"issue":"7","key":"4793_CR57","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/s41592-025-02719-x","volume":"22","author":"B Wen","year":"2025","unstructured":"Wen B, Freestone J, Riffle M, MacCoss MJ, Noble WS, Keich U. Assessment of false discovery rate control in tandem mass spectrometry analysis using entrapment. Nat Methods. 2025;22(7):1454\u201363.","journal-title":"Nat Methods"},{"issue":"2","key":"4793_CR58","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2282790","volume":"15","author":"X Qian","year":"2023","unstructured":"Qian X, Hai W, Chen S, Zhang M, Jiang X, Tang H. Multi-omics data reveals aberrant gut microbiota-host glycerophospholipid metabolism in association with neuroinflammation in APP\/PS1 mice. Gut Microbes. 2023;15(2):2282790.","journal-title":"Gut Microbes"},{"issue":"1","key":"4793_CR59","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128\u201338.","journal-title":"Epidemiology"},{"issue":"9","key":"4793_CR60","doi-asserted-by":"publisher","first-page":"97001","DOI":"10.1289\/EHP12381","volume":"131","author":"X Yang","year":"2023","unstructured":"Yang X, Weber AA, Mennillo E, Secrest P, Chang M, Wong S, et al. Effects of early life oral arsenic exposure on intestinal tract development and lipid homeostasis in neonatal mice: implications for NAFLD development. Environ Health Perspect. 2023;131(9):97001.","journal-title":"Environ Health Perspect"},{"issue":"9","key":"4793_CR61","doi-asserted-by":"publisher","DOI":"10.1289\/EHP4415","volume":"127","author":"L Chi","year":"2019","unstructured":"Chi L, Lai Y, Tu P, Liu CW, Xue J, Ru H, et al. Lipid and cholesterol homeostasis after arsenic exposure and antibiotic treatment in mice: potential role of the microbiota. Environ Health Perspect. 2019;127(9):97002.","journal-title":"Environ Health Perspect"},{"issue":"1","key":"4793_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08411-x","volume":"10","author":"K Soltysik","year":"2019","unstructured":"Soltysik K, Ohsaki Y, Tatematsu T, Cheng J, Fujimoto T. Nuclear lipid droplets derive from a lipoprotein precursor and regulate phosphatidylcholine synthesis. Nat Commun. 2019;10(1):473.","journal-title":"Nat Commun"},{"issue":"5","key":"4793_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2025.100794","volume":"66","author":"MR Luque-Urbano","year":"2025","unstructured":"Luque-Urbano MR, Fernandez-Ramos D, Lopitz-Otsoa F, de Gutierrez Juan V, Bizkarguenaga M, Castro-Espadas L, et al. S-adenosylmethionine deficit disrupts very low-density lipoprotein metabolism promoting liver lipid accumulation in mice. J Lipid Res. 2025;66(5):100794.","journal-title":"J Lipid Res"},{"issue":"1","key":"4793_CR64","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jacl.2024.09.009","volume":"19","author":"J Cole","year":"2025","unstructured":"Cole J, Couture P, Tremblay AJ, Sniderman AD. Variance in the composition and number of VLDL and LDL particles with increasing triglyceride or increasing ApoB concentrations. J Clin Lipidol. 2025;19(1):72\u201382.","journal-title":"J Clin Lipidol"},{"issue":"11","key":"4793_CR65","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.2337\/db22-0313","volume":"71","author":"S Heeboll","year":"2022","unstructured":"Heeboll S, Risikesan J, Ringgaard S, Kumarathas I, Sandahl TD, Gronbaek H, et al. Impaired glucagon-mediated suppression of VLDL-triglyceride secretion in individuals with metabolic dysfunction-associated fatty liver disease (MAFLD). Diabetes. 2022;71(11):2402\u201311.","journal-title":"Diabetes"},{"issue":"17","key":"4793_CR66","doi-asserted-by":"publisher","DOI":"10.1172\/JCI171267","volume":"133","author":"CF Chin","year":"2023","unstructured":"Chin CF, Galam D, Gao L, Tan BC, Wong BH, Chua GL, et al. Blood-derived lysophospholipid sustains hepatic phospholipids and fat storage necessary for hepatoprotection in overnutrition. J Clin Invest. 2023;133(17):e171267.","journal-title":"J Clin Invest"},{"issue":"6","key":"4793_CR67","first-page":"1644","volume":"40","author":"Y Tang","year":"2024","unstructured":"Tang Y, Lin C, Ke C, Tao Y, Huang J, Yang X. Advances in the synthesis of cytidine-5\u2019-diphosphate choline. Chin J Biotechnol. 2024;40(6):1644\u201360.","journal-title":"Chin J Biotechnol"},{"issue":"51","key":"4793_CR68","doi-asserted-by":"publisher","first-page":"17877","DOI":"10.1074\/jbc.REV120.013529","volume":"295","author":"M Tavasoli","year":"2020","unstructured":"Tavasoli M, Lahire S, Reid T, Brodovsky M, McMaster CR. Genetic diseases of the Kennedy pathways for membrane synthesis. J Biol Chem. 2020;295(51):17877\u201386.","journal-title":"J Biol Chem"},{"issue":"45","key":"4793_CR69","doi-asserted-by":"publisher","first-page":"47402","DOI":"10.1074\/jbc.M404027200","volume":"279","author":"RL Jacobs","year":"2004","unstructured":"Jacobs RL, Devlin C, Tabas I, Vance DE. Targeted deletion of hepatic CTP: phosphocholine cytidylyltransferase alpha in mice decreases plasma high density and very low-density lipoproteins. J Biol Chem. 2004;279(45):47402\u201310.","journal-title":"J Biol Chem"},{"issue":"8","key":"4793_CR70","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.3382\/ps\/pez139","volume":"98","author":"XF Dong","year":"2019","unstructured":"Dong XF, Zhai QH, Tong JM. Dietary choline supplementation regulated lipid profiles of egg yolk, blood, and liver and improved hepatic redox status in laying hens. Poult Sci. 2019;98(8):3304\u201312.","journal-title":"Poult Sci"},{"issue":"8","key":"4793_CR71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2314561121","volume":"121","author":"Y Chen","year":"2024","unstructured":"Chen Y, Chen K, Zhu H, Qin H, Liu J, Cao X. Methyltransferase Setd2 prevents T cell-mediated autoimmune diseases via phospholipid remodeling. Proc Natl Acad Sci U S A. 2024;121(8):e2314561121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"4793_CR72","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1002\/jcp.30309","volume":"236","author":"Z Mao","year":"2021","unstructured":"Mao Z, Li T, Zhao H, Wang X, Kang Y, Kang Y. Methylome and transcriptome profiling revealed epigenetic silencing of LPCAT1 and PCYT1A associated with lipidome alterations in polycystic ovary syndrome. J Cell Physiol. 2021;236(9):6362\u201375.","journal-title":"J Cell Physiol"},{"issue":"2","key":"4793_CR73","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1161\/CIRCRESAHA.122.320991","volume":"131","author":"A Domingo-Relloso","year":"2022","unstructured":"Domingo-Relloso A, Makhani K, Riffo-Campos AL, Tellez-Plaza M, Klein KO, Subedi P, et al. Arsenic exposure and human blood DNA methylation and hydroxymethylation profiles in two diverse populations from Bangladesh and Spain. Circ Res. 2022;131(2):e51\u201369.","journal-title":"Circ Res"},{"key":"4793_CR74","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.envint.2018.06.024","volume":"119","author":"X Guo","year":"2018","unstructured":"Guo X, Chen X, Wang J, Liu Z, Gaile D, Wu H, et al. Multi-generational impacts of arsenic exposure on genome-wide DNA methylation and the implications for arsenic-induced skin lesions. Environ Int. 2018;119:250\u201363.","journal-title":"Environ Int"},{"issue":"2","key":"4793_CR75","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrg.2017.80","volume":"19","author":"F Lyko","year":"2018","unstructured":"Lyko F. The DNA methyltransferase family: a versatile toolkit for epigenetic regulation. Nat Rev Genet. 2018;19(2):81\u201392.","journal-title":"Nat Rev Genet"},{"key":"4793_CR76","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev-biochem-103019-102815","volume":"89","author":"Z Chen","year":"2020","unstructured":"Chen Z, Zhang Y. Role of mammalian DNA methyltransferases in development. Annu Rev Biochem. 2020;89:135\u201358.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"4793_CR77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.rbmo.2021.06.030","volume":"44","author":"D Wang","year":"2022","unstructured":"Wang D, Guo C, Li Y, Zhou M, Wang H, Liu J, et al. Oestrogen up-regulates DNMT1 and leads to the hypermethylation of RUNX3 in the malignant transformation of ovarian endometriosis. Reprod Biomed Online. 2022;44(1):27\u201337.","journal-title":"Reprod Biomed Online"},{"key":"4793_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.119108","volume":"304","author":"L Yang","year":"2025","unstructured":"Yang L, Wang W, Zhang A. PARP1 promoter hypermethylation promotes arsenic-induced skin damage by driving telomere dysfunction-mediated keratinocyte senescence. Ecotoxicol Environ Saf. 2025;304:119108.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"6047","key":"4793_CR79","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1126\/science.1210597","volume":"333","author":"S Ito","year":"2011","unstructured":"Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011;333(6047):1300\u20133.","journal-title":"Science"},{"issue":"3","key":"4793_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.100908","volume":"23","author":"G Huang","year":"2020","unstructured":"Huang G, Liu L, Wang H, Gou M, Gong P, Tian C, et al. Tet1 deficiency leads to premature reproductive aging by reducing spermatogonia stem cells and germ cell differentiation. iScience. 2020;23(3):100908.","journal-title":"iScience"},{"issue":"1","key":"4793_CR81","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13059-021-02384-1","volume":"22","author":"A Onodera","year":"2021","unstructured":"Onodera A, Gonzalez-Avalos E, Lio CJ, Georges RO, Bellacosa A, Nakayama T, et al. Roles of TET and TDG in DNA demethylation in proliferating and non-proliferating immune cells. Genome Biol. 2021;22(1):186.","journal-title":"Genome Biol"},{"issue":"1","key":"4793_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-025-09216-z","volume":"8","author":"L Zhao","year":"2025","unstructured":"Zhao L, Jiao X, Li H, Chang Y, Li M, Liu Y, et al. Arsenic promotes ROS-mediated malignant transformation of bronchial epithelial cells by specifically downregulating TXNL1 expression. Commun Biol. 2025;8(1):1827.","journal-title":"Commun Biol"},{"key":"4793_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2025.138736","volume":"494","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Song YP, Wu HY, Zhong FJ, Xue H, Fan YJ, et al. Prenatal arsenic exposure disrupts placental angiogenesis by altering Pdgfb promoter epigenetic modification. J Hazard Mater. 2025;494:138736.","journal-title":"J Hazard Mater"},{"key":"4793_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2022.128511","volume":"430","author":"YP Song","year":"2022","unstructured":"Song YP, Lv JW, Zhao Y, Chen X, Zhang ZC, Fan YJ. DNA hydroxymethylation reprogramming of beta-oxidation genes mediates early-life arsenic-evoked hepatic lipid accumulation in adult mice. J Hazard Mater. 2022;430:128511.","journal-title":"J Hazard Mater"},{"issue":"4","key":"4793_CR85","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/2211-5463.12392","volume":"8","author":"B Veto","year":"2018","unstructured":"Veto B, Szabo P, Bacquet C, Apro A, Hathy E, Kiss J, et al. Inhibition of DNA methyltransferase leads to increased genomic 5-hydroxymethylcytosine levels in hematopoietic cells. FEBS Open Bio. 2018;8(4):584\u201392.","journal-title":"FEBS Open Bio"},{"issue":"7","key":"4793_CR86","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1530\/ERC-17-0009","volume":"24","author":"E Barazeghi","year":"2017","unstructured":"Barazeghi E, Gill AJ, Sidhu S, Norlen O, Dina R, Palazzo FF, et al. A role for TET2 in parathyroid carcinoma. Endocr Relat Cancer. 2017;24(7):329\u201338.","journal-title":"Endocr Relat Cancer"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04793-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04793-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04793-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:03:32Z","timestamp":1777003412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04793-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4793"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04793-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving population survey and animal experiment were in accordance with the ethical standards and were approved by of the Research Ethics Committee of the Guizhou Medical University (population survey approval no. 2019046; animal experiment approval no. 1900217).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"264"}}